2022
DOI: 10.1186/s12906-022-03758-z
|View full text |Cite
|
Sign up to set email alerts
|

Sub-chronic oral toxicity screening of quercetin in mice

Abstract: Background Quercetin is an organic flavonoid present in several fruits and vegetables. The anti-inflammatory, antiviral, antioxidant, cardio-protective, anti-carcinogenic and neuroprotective properties demonstrated by this dietary supplement endorses it as a possible treatment for inflammatory diseases and cancer. Unfortunately, conflicting research has cast uncertainties on the toxicity of quercetin. The main purpose of this study was to determine if quercetin has any toxic properties in mice … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 29 publications
(65 reference statements)
0
9
0
Order By: Relevance
“…However, in a sub-chronic toxicity study carried out by Yao et al [ 124 ], following the daily oral administration of chrysin (1000 mg/kg), the compound significantly decrease body weight, liver weight was increased, there were significant alteration in the hematology, and an LD 50 value of 4350 mg/kg was reported. The results from a sub-chronic toxicity study of quercetin examined in male and female CD2F1 mice administered at 62, 125 and 250 mg/kg indicated that quercetin is safe to CD2F1 mice, as they showed no signs of toxicity, and no changes in hematological and histopathological parameters were observed [ 125 ]. Lucida et al [ 126 ] also confirmed the safety of quercetin in an acute test, with an LD50 value > 1600 mg/kg.…”
Section: Resultsmentioning
confidence: 99%
“…However, in a sub-chronic toxicity study carried out by Yao et al [ 124 ], following the daily oral administration of chrysin (1000 mg/kg), the compound significantly decrease body weight, liver weight was increased, there were significant alteration in the hematology, and an LD 50 value of 4350 mg/kg was reported. The results from a sub-chronic toxicity study of quercetin examined in male and female CD2F1 mice administered at 62, 125 and 250 mg/kg indicated that quercetin is safe to CD2F1 mice, as they showed no signs of toxicity, and no changes in hematological and histopathological parameters were observed [ 125 ]. Lucida et al [ 126 ] also confirmed the safety of quercetin in an acute test, with an LD50 value > 1600 mg/kg.…”
Section: Resultsmentioning
confidence: 99%
“…In the current study we sought to investigate quercetin’s ability to protect against skeletal muscle mass loss in a novel model of cancer and chemotherapy-induced cachexia. We recently showed quercetin was safe at multiple doses [ 32 ] and now show that quercetin partially preserved muscle mass and protected muscle mitochondrial content and quality control in the context of cancer and chemotherapy.…”
Section: Discussionmentioning
confidence: 99%
“…We recently conducted a sub-chronic quercetin toxicity study in CD2F1 mice and found that quercetin had no deleterious effects or toxicities at various dosages [ 32 ]. The purpose of the current study was to examine quercetin’s efficacy in preventing cachexia in C26 tumor-bearing mice treated with 5FU.…”
Section: Introductionmentioning
confidence: 99%
“…Then, a Sham-operation was performed on the mice ( n = 6) or the animals were surgically ovariectomized ( n = 12) under anesthesia. After a week of recovery, the OVX animals were randomly divided into 2 groups: OVX control group and OVX orally administrated with quercetin (50 mg/kg) twice per week following the dosage suggestions from previous studies [ 33 ]. At 4 weeks post treatment, all animals were sacrificed by an overdose of anesthesia and both femurs of the mice were collected and fixed 24 h by 10% neutral formalin solution.…”
Section: Methodsmentioning
confidence: 99%